nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—CYP3A4—prostate cancer	0.142	1	CbGaD
Cephalexin—SLC47A1—Mitoxantrone—prostate cancer	0.129	0.229	CbGbCtD
Cephalexin—ALB—Abiraterone—prostate cancer	0.0472	0.0838	CbGbCtD
Cephalexin—SLC22A8—Conjugated Estrogens—prostate cancer	0.0376	0.0668	CbGbCtD
Cephalexin—ALB—Estrone—prostate cancer	0.0341	0.0606	CbGbCtD
Cephalexin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.034	0.0603	CbGbCtD
Cephalexin—SLC22A8—Estradiol—prostate cancer	0.033	0.0586	CbGbCtD
Cephalexin—CYP2D6—Bicalutamide—prostate cancer	0.0281	0.0498	CbGbCtD
Cephalexin—SLC22A6—Conjugated Estrogens—prostate cancer	0.0262	0.0465	CbGbCtD
Cephalexin—CYP2D6—Abiraterone—prostate cancer	0.0233	0.0413	CbGbCtD
Cephalexin—ALB—Estradiol—prostate cancer	0.0196	0.0348	CbGbCtD
Cephalexin—CYP3A4—Bicalutamide—prostate cancer	0.0178	0.0317	CbGbCtD
Cephalexin—ALB—Prednisone—prostate cancer	0.0168	0.0299	CbGbCtD
Cephalexin—CYP3A4—Estramustine—prostate cancer	0.0166	0.0295	CbGbCtD
Cephalexin—CYP3A4—Abiraterone—prostate cancer	0.0148	0.0262	CbGbCtD
Cephalexin—CYP3A4—Flutamide—prostate cancer	0.0148	0.0262	CbGbCtD
Cephalexin—CYP3A4—Cabazitaxel—prostate cancer	0.0109	0.0194	CbGbCtD
Cephalexin—CYP3A4—Estrone—prostate cancer	0.0107	0.019	CbGbCtD
Cephalexin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00953	0.0169	CbGbCtD
Cephalexin—CYP3A4—Conjugated Estrogens—prostate cancer	0.00699	0.0124	CbGbCtD
Cephalexin—CYP3A4—Mitoxantrone—prostate cancer	0.00636	0.0113	CbGbCtD
Cephalexin—CYP3A4—Estradiol—prostate cancer	0.00614	0.0109	CbGbCtD
Cephalexin—CYP3A4—Prednisone—prostate cancer	0.00528	0.00937	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—prostate cancer	0.0043	0.00763	CbGbCtD
Cephalexin—CYP3A4—Etoposide—prostate cancer	0.00401	0.00712	CbGbCtD
Cephalexin—SLC22A8—urine—prostate cancer	0.00397	0.124	CbGeAlD
Cephalexin—CYP3A4—Docetaxel—prostate cancer	0.00367	0.00651	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—prostate cancer	0.00273	0.00485	CbGbCtD
Cephalexin—CYP3A4—urine—prostate cancer	0.00197	0.0615	CbGeAlD
Cephalexin—CYP2D6—urine—prostate cancer	0.00194	0.0605	CbGeAlD
Cephalexin—SLC47A1—prostate gland—prostate cancer	0.00186	0.0581	CbGeAlD
Cephalexin—SLC47A1—seminal vesicle—prostate cancer	0.00157	0.0491	CbGeAlD
Cephalexin—SLC15A1—epithelium—prostate cancer	0.00146	0.0455	CbGeAlD
Cephalexin—SLC22A8—prostate gland—prostate cancer	0.00142	0.0446	CbGeAlD
Cephalexin—SLC15A1—renal system—prostate cancer	0.00135	0.0422	CbGeAlD
Cephalexin—SLC47A1—renal system—prostate cancer	0.00127	0.0396	CbGeAlD
Cephalexin—SLC47A1—urethra—prostate cancer	0.00124	0.0389	CbGeAlD
Cephalexin—SLC15A2—prostate gland—prostate cancer	0.00124	0.0387	CbGeAlD
Cephalexin—SLC22A5—prostate gland—prostate cancer	0.00108	0.0337	CbGeAlD
Cephalexin—SLC15A2—seminal vesicle—prostate cancer	0.00105	0.0328	CbGeAlD
Cephalexin—SLC22A8—renal system—prostate cancer	0.000971	0.0304	CbGeAlD
Cephalexin—SLC22A5—seminal vesicle—prostate cancer	0.000911	0.0285	CbGeAlD
Cephalexin—SLC15A2—renal system—prostate cancer	0.000844	0.0264	CbGeAlD
Cephalexin—SLC15A2—urethra—prostate cancer	0.000829	0.0259	CbGeAlD
Cephalexin—SLC47A1—testis—prostate cancer	0.000818	0.0256	CbGeAlD
Cephalexin—SLC22A5—renal system—prostate cancer	0.000734	0.023	CbGeAlD
Cephalexin—SLC22A5—urethra—prostate cancer	0.000721	0.0226	CbGeAlD
Cephalexin—ALB—testis—prostate cancer	0.000654	0.0204	CbGeAlD
Cephalexin—Cefazolin—PON1—prostate cancer	0.000653	0.455	CrCbGaD
Cephalexin—SLC47A1—lymph node—prostate cancer	0.000593	0.0185	CbGeAlD
Cephalexin—SLC15A2—testis—prostate cancer	0.000546	0.0171	CbGeAlD
Cephalexin—CYP3A4—renal system—prostate cancer	0.000481	0.0151	CbGeAlD
Cephalexin—SLC22A5—testis—prostate cancer	0.000474	0.0148	CbGeAlD
Cephalexin—ALB—lymph node—prostate cancer	0.000474	0.0148	CbGeAlD
Cephalexin—CYP2D6—renal system—prostate cancer	0.000474	0.0148	CbGeAlD
Cephalexin—SLC15A2—lymph node—prostate cancer	0.000395	0.0124	CbGeAlD
Cephalexin—SLC22A5—lymph node—prostate cancer	0.000344	0.0108	CbGeAlD
Cephalexin—CYP2D6—testis—prostate cancer	0.000306	0.00957	CbGeAlD
Cephalexin—Cefdinir—MPO—prostate cancer	0.000267	0.186	CrCbGaD
Cephalexin—Cefaclor—MPO—prostate cancer	0.000265	0.185	CrCbGaD
Cephalexin—Amoxicillin—CYP2C19—prostate cancer	0.000153	0.107	CrCbGaD
Cephalexin—Fatigue—Mitoxantrone—prostate cancer	0.000118	0.00063	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000118	0.00063	CcSEcCtD
Cephalexin—Vomiting—Goserelin—prostate cancer	0.000118	0.000629	CcSEcCtD
Cephalexin—Breast disorder—Epirubicin—prostate cancer	0.000117	0.000626	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000117	0.000624	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Epirubicin—prostate cancer	0.000117	0.000624	CcSEcCtD
Cephalexin—Rash—Goserelin—prostate cancer	0.000117	0.000624	CcSEcCtD
Cephalexin—Dermatitis—Goserelin—prostate cancer	0.000116	0.000623	CcSEcCtD
Cephalexin—Vomiting—Conjugated Estrogens—prostate cancer	0.000116	0.000623	CcSEcCtD
Cephalexin—Urticaria—Estradiol—prostate cancer	0.000116	0.000623	CcSEcCtD
Cephalexin—Mental disorder—Docetaxel—prostate cancer	0.000116	0.000623	CcSEcCtD
Cephalexin—Immune system disorder—Capecitabine—prostate cancer	0.000116	0.000622	CcSEcCtD
Cephalexin—Abdominal pain—Estradiol—prostate cancer	0.000116	0.00062	CcSEcCtD
Cephalexin—Body temperature increased—Estradiol—prostate cancer	0.000116	0.00062	CcSEcCtD
Cephalexin—Headache—Goserelin—prostate cancer	0.000116	0.00062	CcSEcCtD
Cephalexin—Rash—Conjugated Estrogens—prostate cancer	0.000115	0.000618	CcSEcCtD
Cephalexin—Dermatitis—Conjugated Estrogens—prostate cancer	0.000115	0.000617	CcSEcCtD
Cephalexin—Haemoglobin—Prednisone—prostate cancer	0.000115	0.000616	CcSEcCtD
Cephalexin—Headache—Conjugated Estrogens—prostate cancer	0.000115	0.000614	CcSEcCtD
Cephalexin—Gastritis—Epirubicin—prostate cancer	0.000115	0.000613	CcSEcCtD
Cephalexin—Haemorrhage—Prednisone—prostate cancer	0.000115	0.000613	CcSEcCtD
Cephalexin—Confusional state—Etoposide—prostate cancer	0.000115	0.000613	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Epirubicin—prostate cancer	0.000114	0.000611	CcSEcCtD
Cephalexin—Hallucination—Prednisone—prostate cancer	0.000114	0.00061	CcSEcCtD
Cephalexin—Anaphylactic shock—Etoposide—prostate cancer	0.000114	0.000608	CcSEcCtD
Cephalexin—Mental disorder—Capecitabine—prostate cancer	0.000113	0.000603	CcSEcCtD
Cephalexin—Connective tissue disorder—Prednisone—prostate cancer	0.000113	0.000602	CcSEcCtD
Cephalexin—Feeling abnormal—Mitoxantrone—prostate cancer	0.000113	0.000602	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—prostate cancer	0.000112	0.000601	CcSEcCtD
Cephalexin—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000112	0.000597	CcSEcCtD
Cephalexin—Thrombocytopenia—Etoposide—prostate cancer	0.000111	0.000595	CcSEcCtD
Cephalexin—Eosinophilia—Epirubicin—prostate cancer	0.000111	0.000593	CcSEcCtD
Cephalexin—Skin disorder—Etoposide—prostate cancer	0.00011	0.00059	CcSEcCtD
Cephalexin—Nausea—Goserelin—prostate cancer	0.00011	0.000588	CcSEcCtD
Cephalexin—Nausea—Conjugated Estrogens—prostate cancer	0.000109	0.000582	CcSEcCtD
Cephalexin—Urticaria—Mitoxantrone—prostate cancer	0.000108	0.00058	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—prostate cancer	0.000108	0.00058	CcSEcCtD
Cephalexin—Hypersensitivity—Estradiol—prostate cancer	0.000108	0.000578	CcSEcCtD
Cephalexin—Abdominal pain—Mitoxantrone—prostate cancer	0.000108	0.000578	CcSEcCtD
Cephalexin—Body temperature increased—Mitoxantrone—prostate cancer	0.000108	0.000578	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000108	0.000578	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	0.000108	0.000578	CcSEcCtD
Cephalexin—Pancytopenia—Epirubicin—prostate cancer	0.000106	0.000569	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—prostate cancer	0.000106	0.000568	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000106	0.000566	CcSEcCtD
Cephalexin—Asthenia—Estradiol—prostate cancer	0.000105	0.000563	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—prostate cancer	0.000105	0.00056	CcSEcCtD
Cephalexin—Pruritus—Estradiol—prostate cancer	0.000104	0.000555	CcSEcCtD
Cephalexin—Leukopenia—Docetaxel—prostate cancer	0.000104	0.000554	CcSEcCtD
Cephalexin—Immune system disorder—Prednisone—prostate cancer	0.000103	0.000554	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—prostate cancer	0.000103	0.000549	CcSEcCtD
Cephalexin—Hypersensitivity—Mitoxantrone—prostate cancer	0.000101	0.000538	CcSEcCtD
Cephalexin—Mental disorder—Prednisone—prostate cancer	0.0001	0.000537	CcSEcCtD
Cephalexin—Diarrhoea—Estradiol—prostate cancer	0.0001	0.000537	CcSEcCtD
Cephalexin—Leukopenia—Capecitabine—prostate cancer	0.0001	0.000536	CcSEcCtD
Cephalexin—Convulsion—Docetaxel—prostate cancer	0.0001	0.000536	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—prostate cancer	9.98e-05	0.000534	CcSEcCtD
Cephalexin—Infestation—Epirubicin—prostate cancer	9.98e-05	0.000534	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—prostate cancer	9.9e-05	0.00053	CcSEcCtD
Cephalexin—Arthralgia—Docetaxel—prostate cancer	9.84e-05	0.000527	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—prostate cancer	9.84e-05	0.000526	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Etoposide—prostate cancer	9.8e-05	0.000525	CcSEcCtD
Cephalexin—Asthenia—Mitoxantrone—prostate cancer	9.8e-05	0.000524	CcSEcCtD
Cephalexin—Fatigue—Etoposide—prostate cancer	9.79e-05	0.000524	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	9.78e-05	0.000523	CcSEcCtD
Cephalexin—Cefradine—CYP3A4—prostate cancer	9.72e-05	0.0677	CrCbGaD
Cephalexin—Dizziness—Estradiol—prostate cancer	9.69e-05	0.000519	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—prostate cancer	9.69e-05	0.000518	CcSEcCtD
Cephalexin—Arthralgia—Capecitabine—prostate cancer	9.53e-05	0.00051	CcSEcCtD
Cephalexin—Confusional state—Docetaxel—prostate cancer	9.52e-05	0.000509	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	9.47e-05	0.000507	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—prostate cancer	9.44e-05	0.000505	CcSEcCtD
Cephalexin—Anaphylactic shock—Docetaxel—prostate cancer	9.44e-05	0.000505	CcSEcCtD
Cephalexin—Feeling abnormal—Etoposide—prostate cancer	9.36e-05	0.000501	CcSEcCtD
Cephalexin—Diarrhoea—Mitoxantrone—prostate cancer	9.34e-05	0.0005	CcSEcCtD
Cephalexin—Vomiting—Estradiol—prostate cancer	9.32e-05	0.000499	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—prostate cancer	9.31e-05	0.000498	CcSEcCtD
Cephalexin—Gastrointestinal pain—Etoposide—prostate cancer	9.29e-05	0.000497	CcSEcCtD
Cephalexin—Nervous system disorder—Docetaxel—prostate cancer	9.26e-05	0.000495	CcSEcCtD
Cephalexin—Thrombocytopenia—Docetaxel—prostate cancer	9.24e-05	0.000495	CcSEcCtD
Cephalexin—Rash—Estradiol—prostate cancer	9.24e-05	0.000494	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—prostate cancer	9.24e-05	0.000494	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—prostate cancer	9.24e-05	0.000494	CcSEcCtD
Cephalexin—Dermatitis—Estradiol—prostate cancer	9.23e-05	0.000494	CcSEcCtD
Cephalexin—Confusional state—Capecitabine—prostate cancer	9.21e-05	0.000493	CcSEcCtD
Cephalexin—Headache—Estradiol—prostate cancer	9.18e-05	0.000491	CcSEcCtD
Cephalexin—Skin disorder—Docetaxel—prostate cancer	9.17e-05	0.000491	CcSEcCtD
Cephalexin—Agitation—Prednisone—prostate cancer	9.16e-05	0.00049	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	9.16e-05	0.00049	CcSEcCtD
Cephalexin—Angioedema—Prednisone—prostate cancer	9.11e-05	0.000488	CcSEcCtD
Cephalexin—Urticaria—Etoposide—prostate cancer	9.02e-05	0.000483	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—prostate cancer	9.01e-05	0.000482	CcSEcCtD
Cephalexin—Abdominal pain—Etoposide—prostate cancer	8.98e-05	0.00048	CcSEcCtD
Cephalexin—Body temperature increased—Etoposide—prostate cancer	8.98e-05	0.00048	CcSEcCtD
Cephalexin—Nervous system disorder—Capecitabine—prostate cancer	8.96e-05	0.00048	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—prostate cancer	8.96e-05	0.00048	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—prostate cancer	8.96e-05	0.00048	CcSEcCtD
Cephalexin—Thrombocytopenia—Capecitabine—prostate cancer	8.95e-05	0.000479	CcSEcCtD
Cephalexin—Skin disorder—Capecitabine—prostate cancer	8.88e-05	0.000475	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—prostate cancer	8.85e-05	0.000474	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—prostate cancer	8.8e-05	0.000471	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—prostate cancer	8.78e-05	0.00047	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—prostate cancer	8.73e-05	0.000467	CcSEcCtD
Cephalexin—Nausea—Estradiol—prostate cancer	8.7e-05	0.000466	CcSEcCtD
Cephalexin—Vomiting—Mitoxantrone—prostate cancer	8.68e-05	0.000465	CcSEcCtD
Cephalexin—Convulsion—Prednisone—prostate cancer	8.64e-05	0.000462	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—prostate cancer	8.62e-05	0.000461	CcSEcCtD
Cephalexin—Rash—Mitoxantrone—prostate cancer	8.61e-05	0.000461	CcSEcCtD
Cephalexin—Dermatitis—Mitoxantrone—prostate cancer	8.6e-05	0.00046	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.6e-05	0.00046	CcSEcCtD
Cephalexin—Headache—Mitoxantrone—prostate cancer	8.55e-05	0.000458	CcSEcCtD
Cephalexin—Arthralgia—Prednisone—prostate cancer	8.49e-05	0.000454	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—prostate cancer	8.47e-05	0.000453	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.43e-05	0.000451	CcSEcCtD
Cephalexin—Hypersensitivity—Etoposide—prostate cancer	8.37e-05	0.000448	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—prostate cancer	8.33e-05	0.000446	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.32e-05	0.000446	CcSEcCtD
Cephalexin—Dyspepsia—Docetaxel—prostate cancer	8.31e-05	0.000445	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—prostate cancer	8.29e-05	0.000444	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—prostate cancer	8.29e-05	0.000444	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—prostate cancer	8.19e-05	0.000438	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Docetaxel—prostate cancer	8.15e-05	0.000436	CcSEcCtD
Cephalexin—Asthenia—Etoposide—prostate cancer	8.15e-05	0.000436	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—prostate cancer	8.15e-05	0.000436	CcSEcCtD
Cephalexin—Anaphylactic shock—Prednisone—prostate cancer	8.14e-05	0.000436	CcSEcCtD
Cephalexin—Fatigue—Docetaxel—prostate cancer	8.14e-05	0.000435	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—prostate cancer	8.13e-05	0.000435	CcSEcCtD
Cephalexin—Nausea—Mitoxantrone—prostate cancer	8.11e-05	0.000434	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—prostate cancer	8.09e-05	0.000433	CcSEcCtD
Cephalexin—Dyspepsia—Capecitabine—prostate cancer	8.04e-05	0.00043	CcSEcCtD
Cephalexin—Pruritus—Etoposide—prostate cancer	8.03e-05	0.00043	CcSEcCtD
Cephalexin—Nervous system disorder—Prednisone—prostate cancer	7.98e-05	0.000427	CcSEcCtD
Cephalexin—Skin disorder—Prednisone—prostate cancer	7.91e-05	0.000423	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Capecitabine—prostate cancer	7.89e-05	0.000422	CcSEcCtD
Cephalexin—Fatigue—Capecitabine—prostate cancer	7.88e-05	0.000422	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—prostate cancer	7.85e-05	0.00042	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—prostate cancer	7.84e-05	0.00042	CcSEcCtD
Cephalexin—Feeling abnormal—Docetaxel—prostate cancer	7.78e-05	0.000416	CcSEcCtD
Cephalexin—Diarrhoea—Etoposide—prostate cancer	7.77e-05	0.000416	CcSEcCtD
Cephalexin—Gastrointestinal pain—Docetaxel—prostate cancer	7.72e-05	0.000413	CcSEcCtD
Cephalexin—Feeling abnormal—Capecitabine—prostate cancer	7.53e-05	0.000403	CcSEcCtD
Cephalexin—Dizziness—Etoposide—prostate cancer	7.51e-05	0.000402	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—prostate cancer	7.49e-05	0.000401	CcSEcCtD
Cephalexin—Gastrointestinal pain—Capecitabine—prostate cancer	7.47e-05	0.0004	CcSEcCtD
Cephalexin—Abdominal pain—Docetaxel—prostate cancer	7.46e-05	0.000399	CcSEcCtD
Cephalexin—Body temperature increased—Docetaxel—prostate cancer	7.46e-05	0.000399	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Prednisone—prostate cancer	7.42e-05	0.000397	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—prostate cancer	7.26e-05	0.000389	CcSEcCtD
Cephalexin—Urticaria—Capecitabine—prostate cancer	7.26e-05	0.000388	CcSEcCtD
Cephalexin—Body temperature increased—Capecitabine—prostate cancer	7.22e-05	0.000387	CcSEcCtD
Cephalexin—Abdominal pain—Capecitabine—prostate cancer	7.22e-05	0.000387	CcSEcCtD
Cephalexin—Vomiting—Etoposide—prostate cancer	7.22e-05	0.000386	CcSEcCtD
Cephalexin—Agitation—Epirubicin—prostate cancer	7.17e-05	0.000384	CcSEcCtD
Cephalexin—Dyspepsia—Prednisone—prostate cancer	7.16e-05	0.000383	CcSEcCtD
Cephalexin—Rash—Etoposide—prostate cancer	7.16e-05	0.000383	CcSEcCtD
Cephalexin—Dermatitis—Etoposide—prostate cancer	7.15e-05	0.000383	CcSEcCtD
Cephalexin—Headache—Etoposide—prostate cancer	7.11e-05	0.000381	CcSEcCtD
Cephalexin—Fatigue—Prednisone—prostate cancer	7.02e-05	0.000376	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—prostate cancer	6.98e-05	0.000374	CcSEcCtD
Cephalexin—Hypersensitivity—Docetaxel—prostate cancer	6.95e-05	0.000372	CcSEcCtD
Cephalexin—Asthenia—Docetaxel—prostate cancer	6.77e-05	0.000362	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—prostate cancer	6.76e-05	0.000362	CcSEcCtD
Cephalexin—Nausea—Etoposide—prostate cancer	6.75e-05	0.000361	CcSEcCtD
Cephalexin—Hypersensitivity—Capecitabine—prostate cancer	6.73e-05	0.00036	CcSEcCtD
Cephalexin—Feeling abnormal—Prednisone—prostate cancer	6.71e-05	0.000359	CcSEcCtD
Cephalexin—Pruritus—Docetaxel—prostate cancer	6.68e-05	0.000357	CcSEcCtD
Cephalexin—Gastrointestinal pain—Prednisone—prostate cancer	6.66e-05	0.000356	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—prostate cancer	6.64e-05	0.000355	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—prostate cancer	6.63e-05	0.000355	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.59e-05	0.000353	CcSEcCtD
Cephalexin—Asthenia—Capecitabine—prostate cancer	6.56e-05	0.000351	CcSEcCtD
Cephalexin—Urticaria—Prednisone—prostate cancer	6.47e-05	0.000346	CcSEcCtD
Cephalexin—Pruritus—Capecitabine—prostate cancer	6.46e-05	0.000346	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—prostate cancer	6.46e-05	0.000346	CcSEcCtD
Cephalexin—Diarrhoea—Docetaxel—prostate cancer	6.46e-05	0.000346	CcSEcCtD
Cephalexin—Abdominal pain—Prednisone—prostate cancer	6.43e-05	0.000344	CcSEcCtD
Cephalexin—Body temperature increased—Prednisone—prostate cancer	6.43e-05	0.000344	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—prostate cancer	6.42e-05	0.000344	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—prostate cancer	6.37e-05	0.000341	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—prostate cancer	6.25e-05	0.000335	CcSEcCtD
Cephalexin—Diarrhoea—Capecitabine—prostate cancer	6.25e-05	0.000335	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—prostate cancer	6.24e-05	0.000334	CcSEcCtD
Cephalexin—Dizziness—Docetaxel—prostate cancer	6.24e-05	0.000334	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—prostate cancer	6.23e-05	0.000334	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—prostate cancer	6.18e-05	0.000331	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—prostate cancer	6.14e-05	0.000329	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.1e-05	0.000327	CcSEcCtD
Cephalexin—Dizziness—Capecitabine—prostate cancer	6.04e-05	0.000323	CcSEcCtD
Cephalexin—Vomiting—Docetaxel—prostate cancer	6e-05	0.000321	CcSEcCtD
Cephalexin—Hypersensitivity—Prednisone—prostate cancer	6e-05	0.000321	CcSEcCtD
Cephalexin—Rash—Docetaxel—prostate cancer	5.95e-05	0.000318	CcSEcCtD
Cephalexin—Dermatitis—Docetaxel—prostate cancer	5.95e-05	0.000318	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—prostate cancer	5.94e-05	0.000318	CcSEcCtD
Cephalexin—Headache—Docetaxel—prostate cancer	5.91e-05	0.000316	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—prostate cancer	5.89e-05	0.000315	CcSEcCtD
Cephalexin—Asthenia—Prednisone—prostate cancer	5.84e-05	0.000313	CcSEcCtD
Cephalexin—Vomiting—Capecitabine—prostate cancer	5.81e-05	0.000311	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.8e-05	0.00031	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—prostate cancer	5.78e-05	0.000309	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—prostate cancer	5.77e-05	0.000309	CcSEcCtD
Cephalexin—Rash—Capecitabine—prostate cancer	5.76e-05	0.000308	CcSEcCtD
Cephalexin—Pruritus—Prednisone—prostate cancer	5.76e-05	0.000308	CcSEcCtD
Cephalexin—Dermatitis—Capecitabine—prostate cancer	5.76e-05	0.000308	CcSEcCtD
Cephalexin—Headache—Capecitabine—prostate cancer	5.72e-05	0.000306	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—prostate cancer	5.72e-05	0.000306	CcSEcCtD
Cephalexin—Nausea—Docetaxel—prostate cancer	5.61e-05	0.0003	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—prostate cancer	5.6e-05	0.0003	CcSEcCtD
Cephalexin—Diarrhoea—Prednisone—prostate cancer	5.57e-05	0.000298	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—prostate cancer	5.5e-05	0.000294	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—prostate cancer	5.49e-05	0.000294	CcSEcCtD
Cephalexin—Nausea—Capecitabine—prostate cancer	5.43e-05	0.00029	CcSEcCtD
Cephalexin—Dizziness—Prednisone—prostate cancer	5.38e-05	0.000288	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.37e-05	0.000287	CcSEcCtD
Cephalexin—Feeling abnormal—Epirubicin—prostate cancer	5.25e-05	0.000281	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—prostate cancer	5.21e-05	0.000279	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—prostate cancer	5.18e-05	0.000277	CcSEcCtD
Cephalexin—Vomiting—Prednisone—prostate cancer	5.18e-05	0.000277	CcSEcCtD
Cephalexin—Rash—Prednisone—prostate cancer	5.13e-05	0.000275	CcSEcCtD
Cephalexin—Dermatitis—Prednisone—prostate cancer	5.13e-05	0.000274	CcSEcCtD
Cephalexin—Headache—Prednisone—prostate cancer	5.1e-05	0.000273	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.09e-05	0.000272	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—prostate cancer	5.08e-05	0.000272	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—prostate cancer	5.06e-05	0.000271	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—prostate cancer	5.03e-05	0.000269	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—prostate cancer	5.03e-05	0.000269	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—prostate cancer	4.85e-05	0.00026	CcSEcCtD
Cephalexin—Nausea—Prednisone—prostate cancer	4.83e-05	0.000259	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—prostate cancer	4.82e-05	0.000258	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—prostate cancer	4.69e-05	0.000251	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—prostate cancer	4.68e-05	0.00025	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—prostate cancer	4.66e-05	0.000249	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—prostate cancer	4.66e-05	0.000249	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—prostate cancer	4.57e-05	0.000244	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—prostate cancer	4.5e-05	0.000241	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—prostate cancer	4.36e-05	0.000233	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—prostate cancer	4.34e-05	0.000232	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—prostate cancer	4.23e-05	0.000226	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—prostate cancer	4.21e-05	0.000225	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—prostate cancer	4.17e-05	0.000223	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—prostate cancer	4.05e-05	0.000217	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—prostate cancer	4.03e-05	0.000216	CcSEcCtD
Cephalexin—Rash—Epirubicin—prostate cancer	4.01e-05	0.000215	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—prostate cancer	4.01e-05	0.000215	CcSEcCtD
Cephalexin—Headache—Epirubicin—prostate cancer	3.99e-05	0.000213	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—prostate cancer	3.89e-05	0.000208	CcSEcCtD
Cephalexin—Nausea—Epirubicin—prostate cancer	3.78e-05	0.000202	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—prostate cancer	3.74e-05	0.0002	CcSEcCtD
Cephalexin—Rash—Doxorubicin—prostate cancer	3.71e-05	0.000199	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—prostate cancer	3.71e-05	0.000199	CcSEcCtD
Cephalexin—Headache—Doxorubicin—prostate cancer	3.69e-05	0.000197	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—prostate cancer	3.5e-05	0.000187	CcSEcCtD
Cephalexin—CYP2D6—Metabolism—UMPS—prostate cancer	9.85e-06	0.000133	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AOX1—prostate cancer	9.8e-06	0.000132	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTM3—prostate cancer	9.8e-06	0.000132	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SULT2B1—prostate cancer	9.8e-06	0.000132	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MBTPS1—prostate cancer	9.8e-06	0.000132	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NAGLU—prostate cancer	9.8e-06	0.000132	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—RFK—prostate cancer	9.8e-06	0.000132	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PGAM2—prostate cancer	9.8e-06	0.000132	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SULT1A1—prostate cancer	9.76e-06	0.000132	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ABCG5—prostate cancer	9.76e-06	0.000132	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LDHB—prostate cancer	9.66e-06	0.00013	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PLAU—prostate cancer	9.58e-06	0.000129	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTA1—prostate cancer	9.53e-06	0.000129	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP3A5—prostate cancer	9.48e-06	0.000128	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NAT2—prostate cancer	9.43e-06	0.000127	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTO1—prostate cancer	9.43e-06	0.000127	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HSD3B2—prostate cancer	9.43e-06	0.000127	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CAV1—prostate cancer	9.36e-06	0.000126	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NAT1—prostate cancer	9.29e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—DEGS1—prostate cancer	9.29e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AMACR—prostate cancer	9.29e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SRD5A2—prostate cancer	9.29e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP3A43—prostate cancer	9.29e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PDHA1—prostate cancer	9.15e-06	0.000124	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—TCN2—prostate cancer	9.15e-06	0.000124	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—UCP3—prostate cancer	9.15e-06	0.000124	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA3—prostate cancer	9.15e-06	0.000124	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	9.08e-06	0.000123	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.06e-06	0.000122	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LRP2—prostate cancer	9.04e-06	0.000122	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP2C18—prostate cancer	9.04e-06	0.000122	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PLCB2—prostate cancer	9.04e-06	0.000122	CbGpPWpGaD
Cephalexin—ALB—Metabolism—P4HB—prostate cancer	8.86e-06	0.00012	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HSD17B1—prostate cancer	8.86e-06	0.00012	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HSD3B1—prostate cancer	8.73e-06	0.000118	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC22A3—prostate cancer	8.73e-06	0.000118	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC22A1—prostate cancer	8.62e-06	0.000116	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	8.62e-06	0.000116	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CG—prostate cancer	8.53e-06	0.000115	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.52e-06	0.000115	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—EGF—prostate cancer	8.43e-06	0.000114	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SULT2A1—prostate cancer	8.4e-06	0.000113	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—TBXAS1—prostate cancer	8.37e-06	0.000113	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA4—prostate cancer	8.37e-06	0.000113	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MED12—prostate cancer	8.27e-06	0.000112	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GNG5—prostate cancer	8.2e-06	0.000111	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA2—prostate cancer	8.16e-06	0.00011	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SULT1A1—prostate cancer	8.06e-06	0.000109	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCG5—prostate cancer	8.06e-06	0.000109	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CREBBP—prostate cancer	7.91e-06	0.000107	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOA3—prostate cancer	7.9e-06	0.000107	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—B4GALT4—prostate cancer	7.9e-06	0.000107	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HPGD—prostate cancer	7.9e-06	0.000107	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTA1—prostate cancer	7.87e-06	0.000106	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IGF1—prostate cancer	7.81e-06	0.000105	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTO1—prostate cancer	7.78e-06	0.000105	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NAT2—prostate cancer	7.78e-06	0.000105	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HSD3B2—prostate cancer	7.78e-06	0.000105	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.76e-06	0.000105	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	7.73e-06	0.000104	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HPGDS—prostate cancer	7.54e-06	0.000102	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CD—prostate cancer	7.5e-06	0.000101	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP2C19—prostate cancer	7.49e-06	0.000101	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP2C18—prostate cancer	7.46e-06	0.000101	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PLCB2—prostate cancer	7.46e-06	0.000101	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LRP2—prostate cancer	7.46e-06	0.000101	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TNFRSF21—prostate cancer	7.43e-06	0.0001	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SERPINE1—prostate cancer	7.41e-06	0.0001	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—P4HB—prostate cancer	7.32e-06	9.87e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTT1—prostate cancer	7.31e-06	9.86e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ACHE—prostate cancer	7.31e-06	9.86e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP2A6—prostate cancer	7.23e-06	9.75e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.22e-06	9.75e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTAP—prostate cancer	7.22e-06	9.75e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.2e-06	9.71e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC22A1—prostate cancer	7.12e-06	9.61e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NOS3—prostate cancer	7.08e-06	9.55e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.04e-06	9.5e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.04e-06	9.5e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AKR1C3—prostate cancer	7.03e-06	9.48e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PRKACB—prostate cancer	6.99e-06	9.43e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SULT2A1—prostate cancer	6.94e-06	9.36e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP17A1—prostate cancer	6.92e-06	9.34e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—JAK2—prostate cancer	6.88e-06	9.28e-05	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.84e-06	9.23e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MED12—prostate cancer	6.83e-06	9.21e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.82e-06	9.21e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GNG5—prostate cancer	6.77e-06	9.14e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ACSL4—prostate cancer	6.72e-06	9.06e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HSD17B3—prostate cancer	6.72e-06	9.06e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOA2—prostate cancer	6.59e-06	8.9e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CB—prostate cancer	6.53e-06	8.82e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOA3—prostate cancer	6.52e-06	8.8e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ARG2—prostate cancer	6.44e-06	8.69e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PHGDH—prostate cancer	6.44e-06	8.69e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—UMPS—prostate cancer	6.44e-06	8.69e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LDHB—prostate cancer	6.31e-06	8.52e-05	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	6.31e-06	8.52e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC5A5—prostate cancer	6.29e-06	8.49e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HPGDS—prostate cancer	6.22e-06	8.4e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.2e-06	8.36e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP2C19—prostate cancer	6.18e-06	8.34e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP2E1—prostate cancer	6.14e-06	8.29e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NQO1—prostate cancer	6.07e-06	8.2e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ACHE—prostate cancer	6.04e-06	8.14e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTT1—prostate cancer	6.04e-06	8.14e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IL2—prostate cancer	6e-06	8.1e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—TH—prostate cancer	5.99e-06	8.08e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PDHA1—prostate cancer	5.99e-06	8.08e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA3—prostate cancer	5.99e-06	8.08e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—UCP3—prostate cancer	5.99e-06	8.08e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TCN2—prostate cancer	5.99e-06	8.08e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP2A6—prostate cancer	5.97e-06	8.05e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.95e-06	8.03e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP3A4—prostate cancer	5.92e-06	7.99e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.89e-06	7.95e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP1B1—prostate cancer	5.82e-06	7.86e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AKR1C3—prostate cancer	5.8e-06	7.83e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PRKACB—prostate cancer	5.77e-06	7.79e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.71e-06	7.71e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.71e-06	7.7e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.71e-06	7.7e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GGT1—prostate cancer	5.64e-06	7.61e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOA1—prostate cancer	5.56e-06	7.5e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP19A1—prostate cancer	5.48e-06	7.39e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.47e-06	7.39e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA4—prostate cancer	5.47e-06	7.39e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOA2—prostate cancer	5.44e-06	7.35e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—EP300—prostate cancer	5.38e-06	7.26e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA2—prostate cancer	5.33e-06	7.2e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—RXRA—prostate cancer	5.28e-06	7.13e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCG5—prostate cancer	5.27e-06	7.11e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.27e-06	7.11e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SRC—prostate cancer	5.24e-06	7.06e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.19e-06	7.01e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTA1—prostate cancer	5.15e-06	6.94e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.14e-06	6.94e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—VEGFA—prostate cancer	5.1e-06	6.88e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—COMT—prostate cancer	5.09e-06	6.87e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.09e-06	6.87e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTO1—prostate cancer	5.09e-06	6.87e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NAT2—prostate cancer	5.09e-06	6.87e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP2E1—prostate cancer	5.07e-06	6.84e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTP1—prostate cancer	5.07e-06	6.84e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NQO1—prostate cancer	5.02e-06	6.77e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ITPR1—prostate cancer	4.99e-06	6.73e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—TH—prostate cancer	4.94e-06	6.67e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.9e-06	6.61e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.89e-06	6.6e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PLCB2—prostate cancer	4.88e-06	6.58e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LRP2—prostate cancer	4.88e-06	6.58e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.88e-06	6.58e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.81e-06	6.49e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—P4HB—prostate cancer	4.78e-06	6.46e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—TYMS—prostate cancer	4.71e-06	6.36e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TGFB1—prostate cancer	4.68e-06	6.32e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GGT1—prostate cancer	4.66e-06	6.28e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTM1—prostate cancer	4.66e-06	6.28e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.65e-06	6.28e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOA1—prostate cancer	4.59e-06	6.19e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LPL—prostate cancer	4.57e-06	6.17e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.54e-06	6.12e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.52e-06	6.1e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MED12—prostate cancer	4.46e-06	6.02e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GNG5—prostate cancer	4.43e-06	5.97e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP1A1—prostate cancer	4.41e-06	5.96e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ERCC2—prostate cancer	4.38e-06	5.91e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—RXRA—prostate cancer	4.36e-06	5.89e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—KRAS—prostate cancer	4.34e-06	5.85e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOA3—prostate cancer	4.26e-06	5.75e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—COMT—prostate cancer	4.2e-06	5.67e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTP1—prostate cancer	4.18e-06	5.64e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ITPR1—prostate cancer	4.12e-06	5.55e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTHFR—prostate cancer	4.11e-06	5.55e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HPGDS—prostate cancer	4.07e-06	5.49e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.04e-06	5.45e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPARA—prostate cancer	4.04e-06	5.45e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3CA—prostate cancer	3.98e-06	5.37e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTT1—prostate cancer	3.95e-06	5.32e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ACHE—prostate cancer	3.95e-06	5.32e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.9e-06	5.26e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—TYMS—prostate cancer	3.89e-06	5.25e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TP53—prostate cancer	3.85e-06	5.2e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTM1—prostate cancer	3.84e-06	5.19e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CAV1—prostate cancer	3.8e-06	5.12e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.79e-06	5.12e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PRKACB—prostate cancer	3.77e-06	5.09e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LPL—prostate cancer	3.77e-06	5.09e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.74e-06	5.04e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.64e-06	4.92e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.63e-06	4.89e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ERCC2—prostate cancer	3.61e-06	4.88e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOA2—prostate cancer	3.56e-06	4.8e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CG—prostate cancer	3.46e-06	4.66e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTHFR—prostate cancer	3.4e-06	4.58e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.4e-06	4.58e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARA—prostate cancer	3.33e-06	4.5e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.32e-06	4.47e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NQO1—prostate cancer	3.28e-06	4.42e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—INS—prostate cancer	3.27e-06	4.42e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—AKT1—prostate cancer	3.25e-06	4.39e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TH—prostate cancer	3.23e-06	4.36e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CREBBP—prostate cancer	3.21e-06	4.32e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.14e-06	4.24e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CAV1—prostate cancer	3.13e-06	4.23e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GGT1—prostate cancer	3.05e-06	4.11e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CD—prostate cancer	3.04e-06	4.1e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOA1—prostate cancer	3e-06	4.05e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.96e-06	3.99e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NOS3—prostate cancer	2.87e-06	3.87e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.85e-06	3.85e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—RXRA—prostate cancer	2.85e-06	3.85e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—COMT—prostate cancer	2.75e-06	3.71e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTP1—prostate cancer	2.74e-06	3.69e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—INS—prostate cancer	2.7e-06	3.65e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ITPR1—prostate cancer	2.69e-06	3.63e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CB—prostate cancer	2.65e-06	3.57e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CREBBP—prostate cancer	2.65e-06	3.57e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTGS2—prostate cancer	2.62e-06	3.54e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—TYMS—prostate cancer	2.54e-06	3.43e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTM1—prostate cancer	2.51e-06	3.39e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.51e-06	3.39e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LPL—prostate cancer	2.47e-06	3.33e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.38e-06	3.21e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NOS3—prostate cancer	2.37e-06	3.2e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ERCC2—prostate cancer	2.36e-06	3.19e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTEN—prostate cancer	2.29e-06	3.09e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTHFR—prostate cancer	2.22e-06	3e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.19e-06	2.95e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—EP300—prostate cancer	2.18e-06	2.95e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARA—prostate cancer	2.18e-06	2.94e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTGS2—prostate cancer	2.17e-06	2.92e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CAV1—prostate cancer	2.05e-06	2.76e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTEN—prostate cancer	1.89e-06	2.55e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.87e-06	2.52e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—EP300—prostate cancer	1.8e-06	2.43e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—INS—prostate cancer	1.77e-06	2.38e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CREBBP—prostate cancer	1.73e-06	2.33e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.64e-06	2.21e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3CA—prostate cancer	1.61e-06	2.18e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NOS3—prostate cancer	1.55e-06	2.09e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.43e-06	1.93e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTGS2—prostate cancer	1.42e-06	1.91e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.33e-06	1.8e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AKT1—prostate cancer	1.32e-06	1.78e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTEN—prostate cancer	1.24e-06	1.67e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—EP300—prostate cancer	1.18e-06	1.59e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AKT1—prostate cancer	1.09e-06	1.47e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.72e-07	1.18e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AKT1—prostate cancer	7.12e-07	9.61e-06	CbGpPWpGaD
